ondansetron has been researched along with cisapride in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 8 (42.11) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderó, JM; del Río, J; García, E; Lasheras, B; Monge, A; Palop, JA; Peña, MC; Roca, J; Romero, G | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Fujiwara, I; Harada, H; Hirokawa, Y; Kato, S; Suzuki, K; Yoshida, N; Yoshikawa, T | 1 |
| Keserü, GM | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Jia, L; Sun, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Sen, S; Sinha, N | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Galligan, JJ; North, RA; Tonini, M | 1 |
| Cesana, R; Donetti, A; Ladinsky, H; Rizzi, CA; Sagrada, A; Schiantarelli, P; Schiavi, GB; Schiavone, A | 1 |
| Güller, R; Jost, G; Reichlin, B | 1 |
| Kamato, T; Miyata, K; Nagakura, Y; Naitoh, Y; Yamano, M | 1 |
| Hirata, T; Kato, S; Nishiwaki, H; Takeuchi, K | 1 |
| Kamato, T; Miyata, K; Nagakura, Y; Yamano, M | 1 |
| Baltzer, L; Grant, SC; Hinckley, L; Kris, MG; Miller, VA; Pisters, KM; Pizzo, BA | 1 |
| Gupta, YK; Kacker, V; Mehta, VS | 1 |
2 trial(s) available for ondansetron and cisapride
| Article | Year |
|---|---|
[Colonic preparation with sodium phosphate. Prospective, randomized, placebo-controlled double blind study with various antiemetics].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics; Cathartics; Cisapride; Colonoscopy; Double-Blind Method; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Phosphates; Piperidines; Prospective Studies; Vomiting | 1996 |
Oral cisapride for the control of delayed vomiting following high-dose cisplatin.
Topics: Abdominal Pain; Administration, Oral; Aged; Antiemetics; Antineoplastic Agents; Cisapride; Cisplatin; Colic; Confidence Intervals; Dexamethasone; Drug Combinations; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Ondansetron; Vomiting | 1999 |
17 other study(ies) available for ondansetron and cisapride
| Article | Year |
|---|---|
Synthesis of 2-piperazinylbenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.
Topics: Animals; Benzothiazoles; Binding, Competitive; Cerebral Cortex; Female; Gastric Emptying; Granisetron; Guinea Pigs; Ileum; Male; Molecular Structure; Mucous Membrane; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 1994 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Topics: Animals; Antiemetics; Azepines; Brain; Crystallography, X-Ray; Dogs; Dopamine Antagonists; Ferrets; In Vitro Techniques; Models, Molecular; Pyridines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship | 2003 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum.
Topics: Acetylcholine; Animals; Cisapride; Gastrointestinal Motility; Guinea Pigs; Ileum; Imidazoles; In Vitro Techniques; Indoles; Membrane Potentials; Ondansetron; Peristalsis; Piperidines; Serotonin; Serotonin Antagonists; Synapses; Synaptic Transmission; Tropisetron | 1989 |
Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cisapride; Dogs; Dose-Response Relationship, Drug; Female; Gastric Emptying; Gastrointestinal Motility; In Vitro Techniques; Male; Muscle Denervation; Neostriatum; Ondansetron; Piperidines; Serotonin Antagonists; Serotonin Receptor Agonists; Stomach; Swine; Tumor Cells, Cultured | 1994 |
Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice.
Topics: Adrenergic alpha-Agonists; Animals; Benzamides; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Cisapride; Clonidine; Gastrointestinal Transit; Intestines; Male; Mice; Mice, Inbred C57BL; Neostigmine; Ondansetron; Piperidines; Receptors, Serotonin; Serotonin Antagonists | 1996 |
Gastric motility and mucosal ulcerogenic responses induced by prokinetic drugs in rats under prostaglandin-deficient conditions.
Topics: Animals; Cisapride; Dose-Response Relationship, Drug; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrointestinal Agents; Gastrointestinal Motility; Indomethacin; Male; Metoclopramide; Ondansetron; Piperidines; Prostaglandin Antagonists; Prostaglandins; Rats; Rats, Sprague-Dawley; Stomach; Stomach Ulcer | 1997 |
Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
Topics: Animals; Benzamides; Benzimidazoles; Blood Glucose; Cisapride; Diabetes Mellitus, Experimental; Gastric Emptying; Gastrointestinal Motility; Gastroparesis; Granisetron; Male; Morpholines; Ondansetron; Piperidines; Pyrroles; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Vagotomy | 1997 |
Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats.
Topics: Acute Disease; Analgesics, Non-Narcotic; Animals; Antihypertensive Agents; Antipsychotic Agents; Bretylium Compounds; Carbachol; Cisapride; Clonidine; Consciousness; Female; Gastric Emptying; Gastrointestinal Agents; Intracranial Hypertension; Intracranial Pressure; Male; Ondansetron; Prazosin; Rats; Rats, Wistar; Reference Values; Stomach | 1999 |